versiti
Dec 12, 2025, 06:35
Genotyping More Than 300,000 Blood Donors by Versiti
Versiti Blood Research Institute shared a post on LinkedIn:
“Incredible work by our colleagues across Versiti! This case is a powerful example of how decades of scientific investment (in this case, genotyping more than 300,000 blood donors) translates directly into lifesaving patient outcomes.”
Quoting Versiti Inc.’s post:
“In response to an urgent request from a major West Coast medical center, the National Blood Exchange reached out across member facilities, asking if any of them could quickly address a critical need for a patient. Versiti answered the call.
Read the full story.”
Follow the latest in Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH